Ladrx Corp
SEC CIK 799698 · cytr · last insider filing 2024-01-29
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Claiborne Cary J | Director | filed 2022–2024 |
| Simpson Jennifer K. | Director | filed 2021–2024 |
| Caldwell Joel K | Director | filed 2017–2024 |
| Brien Earl W | Director | filed 2016–2020 |
| Kriegsman Steven A | Director · President, CEO, Board Chairman | filed 2006–2020 |
| Ignarro Louis | Director | filed 2006–2020 |
| Rubinfeld Joseph | Director | filed 2006–2016 |
| Chawla Anita J | Director | filed 2015–2016 |
| Cohen Cheryl | Director | filed 2015–2015 |
| Selter Eric JAY | Director | filed 2015–2015 |
| Wennekamp Richard L. | Director | filed 2006–2014 |
| Link MAX | Director | filed 2006–2013 |
| Selter Marvin R | Director | filed 2006–2013 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Caloz John Y | Chief Financial Officer | filed 2007–2024 |
| Snowdy Stephen | Chief Executive Officer | filed 2022–2024 |
| Curtis Eric | Pres., Chief Operating Officer | filed 2018–2018 |
| Kratz Felix | Vice President Drug Discovery | filed 2018–2018 |
| Chawla Shanta M.D. | Senior VP-Drug Development | filed 2017–2017 |
| Levitt Daniel J | EVP and Chief Medical Officer | filed 2009–2016 |
| Wieland Douglas Scott | Sr. VP - Drug Development | filed 2008–2016 |
| Ware Olivia C | Chief Commercial Officer | filed 2016–2016 |
| Levin Ben | VP-Legal Affairs/Secty/GenCnsl | filed 2006–2015 |
| Geyer David Scott | Sr. V.P. of Manufacturing | filed 2009–2011 |
| Barber Jack R | Sr. VP - Drug Development | filed 2006–2009 |
| Shah Jaisim | Sr. VP - Business Development | filed 2009–2009 |
| Fogelman Mitchell K | Chief Financial Officer | filed 2007–2008 |
| Ng Shi Chung | Sr. VP Research & Development | filed 2007–2008 |
| Tepper Mark | Vice President | filed 2007–2007 |
| Natalizio Matt | Chief Financial Officer | filed 2006–2006 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.